Protons allow delivery of RT with greater sparing of OARs as dose builds up to a peak and then falls off steeply (e.g. chordoma, paediatric malignancies). There is no UK facility delivering proton treatment in these clinical settings and patients are currently referred abroad via the NHS Proton Overseas Programme following set referral criteria. There are plans for 2 new proton facilities in the UK by 2018.